Autor: "Baig SU" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Hyperimmune anti-COVID-19 IVIG (C-IVIG) Therapy for Passive Immunization of Severe and Critically Ill COVID-19 Patients: A structured summary of a study protocol for a randomised controlled trial.
Autorzy:: Ali S; Dow College of Biotechnology, Dow University of Health Sciences, Karachi, Pakistan. .
Luxmi S; Dow University Hospital, Dow University of Health Sciences, Karachi, Pakistan.
Anjum F; Dow Research Institute of Biotechnology and Biomedical Sciences, Dow University of Health Sciences, Karachi, Pakistan.
Muhaymin SM; Dow College of Biotechnology, Dow University of Health Sciences, Karachi, Pakistan.
Uddin SM; Dow College of Biotechnology, Dow University of Health Sciences, Karachi, Pakistan.
Ali A; Dow College of Biotechnology, Dow University of Health Sciences, Karachi, Pakistan.
Ali MR; Dow College of Biotechnology, Dow University of Health Sciences, Karachi, Pakistan.
Tauheed S; Dow International Medical College, Dow University of Health Sciences, Karachi, Pakistan.
Khan M; Dow College of Biotechnology, Dow University of Health Sciences, Karachi, Pakistan.
Bajwa M; Dow University Hospital, Dow University of Health Sciences, Karachi, Pakistan.
Baig SU; Dow University Hospital, Dow University of Health Sciences, Karachi, Pakistan.
Shalim E; Dow College of Biotechnology, Dow University of Health Sciences, Karachi, Pakistan.
Ahmed I; Dow College of Biotechnology, Dow University of Health Sciences, Karachi, Pakistan.
Khan AS; National Control Laboratory for Biologicals, Islamabad, Pakistan.
Quraishy S; Dow University of Health Sciences, Karachi, Pakistan.; Pokaż więcej
Źródło:: Trials [Trials] 2020 Nov 02; Vol. 21 (1), pp. 905. Date of Electronic Publication: 2020 Nov 02.
Typ publikacji:: Clinical Trial Protocol; Letter
MeSH Terms:: Immunoglobulins, Intravenous*/administration & dosage
Immunoglobulins, Intravenous*/adverse effects
Coronavirus Infections/*therapy
Immunization, Passive/*methods
Pneumonia, Viral/*therapy
Adult ; Betacoronavirus/isolation & purification ; COVID-19 ; Critical Illness/therapy ; Female ; Humans ; Immunologic Factors/administration & dosage ; Immunologic Factors/adverse effects ; Male ; Pandemics ; Randomized Controlled Trials as Topic ; SARS-CoV-2 ; Severity of Illness Index ; Treatment Outcome ; COVID-19 Serotherapy

Opinia redakcyjna

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Baig SU"" wg kryterium: Autor

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Język